Group items tagged

If you're a prospective mobile entrepreneur keen to take your idea or business to the next level, you just might get your chance at MaRS on Monday, March 2nd.

MobileMonday Toronto, the mobile industry-networking group, will open the floor for prospective mobile entrepreneurs to pitch their business ideas to some of Canada's leading VCs. The focus of this session will be raising capital for mobile ventures. It will include participation from Sean Wise of Wise Mentor Capital, Ted Anderson, Managing General Partner from Ventures West, Marc Faucher from JLA Ventures Fund and Matt Golden from RBC Venture Partners Fund.

MaRS District Collaboration Centre in Toronto CIBC Presents Entrepreneurship 101. March 4th re-webcast of the session titled: How to Get Money From a VC Every entrepreneur wants to know the secrets for successfully pitching a VC or an angel. Join guest lecturer Peter Tolnai from Orchard Capital along with Chris Arsenault of iNovia Capital and Michael Midmer of Rosetta Capital, all prominent VCs who tell you their secrets for making a successful pitch.  They also host a Q&A session in which the panel  answers your questions directly without saying, "Come back in a few months when you've made some more revenue traction!"   http://www.marsdd.com/Events/Event-Calendar/Ent101/2009/what-investors-look-for-03042009.html

Last Wednesday I had the pleasure of participating in one of the MaRS District courses up in Toronto – CIBC Presents Entrepreneurship 101.

For Dr. John Evans, growing a strong biotechnology industry is much the same: cities must provide a nurturing environment where science and business can thrive together.

That's why Evans, former president of the University of Toronto and current chairman of Torstar Corp., is spearheading the $345-million Medical and Related Science initiative, or MaRS--a petri dish of sorts for commercializing science research. "A lot of intellectual property is being commercialized outside Canada," says Evans. "I think we've been slow in realizing just how important technology developments are to the economic future of the country. MaRS is an attempt to give this a kick into a higher gear." The centrepiece of the MaRS plan, which will officially launch May 12, is a 1.3-million-square-foot, five-building complex in downtown Toronto that will provide office and lab space for small and medium-size companies and incubators, including the not-for-profit Toronto Biotechnology Commercialization Centre. While Evans is reluctant to limit its scope, MaRS will generally focus on health-related technologies, from new drugs and genetic treatments to medical devices and imaging software. Branded a "convergence centre," it will also house a careful mix of support services: intellectual property lawyers, accountants, marketing experts, government funding organizations and venture capital financiers. Plus, start-ups will have access to all the latest equipment on site. For instance, MaRS is in talks with MDS Sciex to supply mass spectrometers, used in proteomics research.

But MaRS will be more than just a New Economy real estate development. Evans's intention is to funnel tenants' rent money into services--such as entrepreneurship seminars and angel-matching programs--that MaRS will offer to the broader biotech community. That's why MaRS's location is key: the centre will be built in the heart of what Toronto has dubbed the "Discovery District," a two-square-kilometre chunk of the downtown core, encompassing U of T and four major hospitals. From there, MaRS hopes to act as a network hub across Ontario, with links to research-intensive universities. "None of them," says Evans, "have the critical mass to put it all together on their own."